Figure 2.

Lipo-CRX treatment contributes to protection of THP-1 macrophages from in vitro infection with two different intracellular bacterial pathogens. a. THP-1 macrophages were pretreated with agonists then infected with S. Typhimurium. Intracellular bacteria were measured in triplicate wells for each agonist. b. A similar titration experiment was performed in THP-1 macrophages using the S19 vaccine strain of B. abortus. These experiments were each repeated 3 times and representative data are shown. For A,*p < 0.05 as measured by one-way ANOVA. For B, *p < 0.05 between LPS positive and medium negative controls as measured by Student's t-test.